Y Intercept (Hong Kong) LTD Bio Rad Laboratories, Inc. Transaction History

Y Intercept (Hong Kong) LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$263.97 - $344.64 $1.76 Million - $2.3 Million	6,679 New	6,679 $2.23 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $1.1 Million - $1.33 Million	3,150 New	3,150 $1.13 Million
Q1 2023 May 09, 2023	BUY	$418.69 - $503.0 $438,368 - $526,641	1,047 New	1,047 $501,000
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $1.33 Million - $1.73 Million	-3,793 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$412.59 - $563.26 $1.56 Million - $2.14 Million	3,793 New	3,793 $1.58 Million
Q2 2022 Aug 08, 2022	SELL	$463.67 - $597.16 $867,526 - $1.12 Million	-1,871 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $981,470 - $1.38 Million	1,871 New	1,871 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $1.57 Million - $1.76 Million	-2,219 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $1.46 Million - $1.83 Million	2,219 New	2,219 $1.66 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $337,334 - $379,688	-585 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$547.01 - $662.35 $320,000 - $387,474	585 New	585 $330,000

458

17.7M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.51B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.